PlainRecalls
FDA Drug Low Class III Terminated

Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.

Reported: November 25, 2015 Initiated: November 2, 2015 #D-0235-2016

Product Description

Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for impurities.

Details

Units Affected
4,609 Packages
Distribution
US Nationwide including Puerto Rico
Location
Rockford, IL

Frequently Asked Questions

What product was recalled?
Meclizine Hydrochloride Tablets, USP, 25 mg Tablets, Packaged in 10 x 10 Tablet Blister Pack Packages, Rx Only. Manufactured by: Par Pharmaceutical Companies, Inc., Spring Valley, NY 10977. Mylan. NDC: 51079-090-20.. Recalled by Mylan Institutional, Inc. (d.b.a. UDL Laboratories). Units affected: 4,609 Packages.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for impurities.
Which agency issued this recall?
This recall was issued by the FDA Drug on November 25, 2015. Severity: Low. Recall number: D-0235-2016.